Therapeutically active alpha-MSH analogues

Details for Australian Patent Application No. 2005335905 (hide)

Owner Action Pharma A/S

Inventors Jonassen, Thomas Engelbrecht Norkild; Nielsen, Soren; Frokiaer, Jorgen; Larsen, Bjarne Due

Agent FB Rice

Pub. Number AU-B-2005335905

PCT Pub. Number WO2007/022774

Filing date 26 August 2005

Wipo publication date 1 March 2007

Acceptance publication date 21 July 2011

International Classifications

C07K 14/685 (2006.01) Peptides having more than 20 amino acids

A61K 38/34 (2006.01) Medicinal preparations containing peptides

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/022774 Priority application(s): WO2007/022774

21 July 2011 Application Accepted

  Published as AU-B-2005335905

1 September 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 15 Aug 2011. Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 2006

12 January 2012 Standard Patent Sealed

13 September 2012 Assignment Registered

  Action Pharma A/S The patent has been assigned to Abbott Laboratories

4 October 2012 Assignment Registered

  Abbott Laboratories The patent has been assigned to AbbVie Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005335919-Fan case reinforcement in a gas turbine jet engine

2005335904-Hearing aid with increased acoustic bandwidth